Data Integrity:
Foundation of Compliance
Read Full Article!
Understanding FDA's Perspective
Medical product manufacturers must understand the FDA's perspective to identify and address data integrity gaps in systems and procedural controls.
Read Full Article!
Challenges in Ensuring Reliable Data
From lack of awareness to a "whatever it takes" culture, companies face obstacles to maintaining reliable data, creating FDA compliance risk.
Read Full Article!
Focus on Both Deliberate
and
Unintentional Conduct
Data integrity gaps, whether intentional or unintentional, pose serious compliance risks, emphasizing the importance of a comprehensive approach.
Read Full Article!
Serious Consequences for Noncompliance
Regulators, including the FDA, are indifferent to the cause of data integrity gaps, underscoring the serious consequences for noncompliance.
Read Full Article!
Applying a Risk-Based Approach
It is necessary to apply a risk-based approach to data integrity, categorizing gaps into known, unknown, and documented, and addressing them systematically.
Read Full Article!
Data Integrity:
Foundation of Compliance